Medicare Enrolled

Dr. Melinda Conroy, D.O.

Dermatology · Lakeway, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
401 RANCH ROAD 620 S STE 200, Lakeway, TX 78734
5126100549
In practice since 2008 (18 years)
NPI: 1760650428 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Conroy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Conroy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Conroy

Dr. Melinda Conroy is a dermatology in Lakeway, TX, with 18 years in practice. Based on federal Medicare data, Dr. Conroy performed 2,808 Medicare services across 1,548 unique beneficiaries.

Between the years covered by Open Payments, Dr. Conroy received a total of $11,347 from 43 pharmaceutical and/or device companies across 551 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Conroy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 43% volume in TX$ $11,347 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,808
Medicare services
Top 43% in TX for dermatology
1,548
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~156 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-141,027$5$14
Office visit, established patient (30-39 min)455$85$260
Destruction of precancerous skin growth, 1300$35$140
Destruction of skin growths (warts/lesions), 1-14294$79$239
Skin biopsy, tangential202$64$213
Office visit, established patient (10-19 min)130$40$115
Office visit, established patient (20-29 min)92$62$184
Biopsy of related skin growth, each additional growth77$41$105
New patient office visit (45-59 min)64$112$338
Destruction of precancer skin growth, 15 or more growths38$113$352
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm28$119$364
Destruction of skin growth, 15 or more growths21$88$278
Acne surgery20$80$243
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm20$226$635
Punch biopsy, first skin growth16$94$264
New patient office visit (30-44 min)13$66$227
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm11$70$359
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
10.5% medium
88.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,347
Total received (2018-2024)
Avg $1,621/year across 7 years
Top 23% in TX for dermatology
43
Companies
551
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,416 (91.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$931 (8.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,232
2023
$1,449
2022
$2,110
2021
$1,130
2020
$778
2019
$2,448
2018
$1,202

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,131
Galderma Laboratories, L.P.
$1,023
Biofrontera Inc.
$709
LEO Pharma Inc.
$668
ABBVIE INC.
$661
PFIZER INC.
$466
Merz North America, Inc.
$456
Regeneron Healthcare Solutions, Inc.
$455
Sun Pharmaceutical Industries Inc.
$438
Incyte Corporation
$408
AbbVie Inc.
$369
AbbVie, Inc.
$365
Novartis Pharmaceuticals Corporation
$345
Ortho Dermatologics, a division of Bausch Health US, LLC
$344
Lilly USA, LLC
$292
Amgen Inc.
$286
Allergan Inc.
$250
E.R. Squibb & Sons, L.L.C.
$225
Almirall LLC
$222
GENZYME CORPORATION
$199
UCB, Inc.
$198
Janssen Scientific Affairs, LLC
$188
Medimetriks Pharmaceuticals, Inc.
$185
EPI Health, LLC
$181
MERZ NORTH AMERICA, INC.
$173
SUN PHARMACEUTICAL INDUSTRIES INC.
$160
Allergan, Inc.
$154
VYNE Pharmaceuticals Inc.
$138
Arcutis Biotherapeutics, Inc.
$124
Journey Medical Corporation
$106
Mayne Pharma Inc.
$103
MAYNE PHARMA INC.
$77
Aclaris Therapeutics, Inc.
$40
Celgene Corporation
$38
Exeltis, USA Inc.
$36
DERMIRA, INC.
$34
Mylan Pharmaceuticals Inc.
$22
Verrica Pharmaceuticals Inc.
$21
Promius Pharma LLC
$15
DUSA Pharmaceuticals, Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
PruGen, Inc. Pharmaceuticals
$12
MAYNE PHARMA COMMERCIAL LLC
$3
Top 3 companies account for 25.2% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Ameluz · BLU-U · BOTOX · BRYHALI · Bensal HP · Bimzelx · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · Clindacin P · Clindamycin Phosphate and Benzoyl Peroxide · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DYSPORT · ENSTILAR · EPIDUO FORTE · EUCRISA · Ecoza · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Klisyri · LIBTAYO · Neo-Synalar · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SORILUX · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · Sumadan Wash · TALTZ · TREMFYA · Tremfya · Veltin · WYNZORA · Winlevi · XEOMIN · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $404 per 100 Medicare services performed
Looking for a dermatology in Lakeway?
Compare dermatologys in the Lakeway area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
137
Per 100K population
10.5
County median income
$97,169
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER- AUSTIN
9.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Conroy is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Conroy experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Conroy performed 1,027 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Conroy receive payments from pharmaceutical companies?
Yes. Dr. Conroy received a total of $11,347 from 43 companies across 551 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Conroy's costs compare to other dermatologys in Lakeway?
Dr. Conroy's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Conroy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →